Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF

AIM: Patients hospitalized for acute heart failure (AHF) differ with respect of many clinical characteristics which may influence their prognosis and response to treatment. We have assessed possible differences in the effects of serelaxin on dyspnoea relief, 60 Day outcomes and 180 Day mortality acr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Metra, Marco, Ponikowski, Piotr, Cotter, Gad, Davison, Beth A., Felker, G. Michael, Filippatos, Gerasimos, Greenberg, Barry H., Hua, Tsushung A., Severin, Thomas, Unemori, Elaine, Voors, Adriaan A., Teerlink, John R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2013
Konular:
Esc Fasttrack
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3800849/
https://ncbi.nlm.nih.gov/pubmed/23999454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/eht371
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller